Ultragenyx Pharmaceutical (RARE) Q4 2016 Earnings

7NovConfirmed
Q1 2016
Q2 2016
Aug 16
Q4 2016
-1.64
-1.47
-1.3
-1.13

Details

Expected EPS
-1.51
Actual EPS
-1.64
Surprise EPS
-0.13
Surprise Percent
+8.61%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.64 per share for Q4 2016.

0 Comments

Share your thoughts